Efficacy and Safety of Rivaroxaban, Apixaban, and Edoxaban for Nonvalvular Atrial Fibrillation Based on Blood Coagulation Activity and Drug Plasma Concentration: SETtsu and North Osaka Multicenter Direct Oral AntiCoagulant (SET DOAC) Registry
基于血液凝固活性和药物血浆浓度的利伐沙班、阿哌沙班和艾多沙班治疗非瓣膜性房颤的疗效和安全性：SETtsu和北大阪多中心直接口服抗凝剂（SET DOAC）注册研究
期刊:Pharmaceuticals
影响因子:4.8
doi:10.3390/ph17111431
Suwa, Michihiro; Morii, Isao; Kino, Masaya; Matsui, Yumie; Yoshinaga, Masahiro; Takahashi, Hiroki; Takagi, Masahiko; Yoshida, Akira; Ichikawa, Minoru; Nakajima, Osamu; Tanimura, Mitsuhiro; Shimoyama, Hisashi; Saitoh, Hiroyuki; Sasaki, Isao; Suzuki, Takeshi; Uemae, Satoshi
